


Working to drive equitable access to reliable diagnosis around the world through collective action. #DiagnosisForAll


📢 Don’t miss our request for proposals (RFP): TB scientist for Bioneer Q-RFIA TB clinical evaluation Application deadline: 19 November 2026 More information: finddx.org/wp-content/upload… #DiagnosisForAll #EndTB #clinicalevaluation

📢Explore our latest calls for partners: Request for proposals (RFP): HQ statutory audit Deadline: 22 October 2026 Expression of interest (EOI): manufacturers of continuous glucose monitoring (CGM) devices willing to test practical access models for LMICs Deadline: 31 October 2026 EOI: in-vitro diagnostic (IVD) partner to apply to a Horizon Europe call for the translation of a host-response mRNA signature to a portable point-of-care molecular diagnostic platform and advancing the assay to market in LMICs Deadline: 6 November 2026 More info: finddx.org/about-us/donors-a…

UNGA adopts the Political Declaration on pandemic preparedness. Thanks @ArmeniaUN & @RwandaUN for your leadership. The #100DaysMission is now recognized in a UN political declaration. Diagnostics first, made & accessible locally and regionally. @WHO @IPPSecretariat @CEPIvaccines

Heading to #WHS2026? Join FIND’s CEO Dr Jutta Reinhard-Rupp & the Global Diagnostics Coalition on Oct 13 for "Driving collective action to close the diagnostic gap." Let’s mobilize support & investment for equitable access to testing. #DiagnosisForAll #WorldHealthSummit #WHS2026 #GlobalHealth #Diagnostics

📢The FIND Board has officially announced the appointment of Dr Jutta Reinhard-Rupp as Chief Executive Officer of FIND, following her successful tenure as Interim CEO since May 2026. Under her leadership, FIND continues to advance breakthrough diagnostic solutions that support its vital mission: ensuring equitable access to reliable diagnosis worldwide. Read the announcement: finddx.org/publications-and-… #DiagnosisForAll

What can investments in global health make possible? Through @EDCTP, EU investments advance new health tools, build scientific capacity & attract additional funding, with every €1 mobilizing more than €1 from other sources. Read our paper: bit.ly/4xKn21U

The 100 Days Mission seeks to deliver diagnostics, treatments & vaccines within 100 days of a pandemic threat. Today at #DevexUNGA81, our key partners @IPPSecretariat @DNDi @CEPIvaccines @UNITAID @MedsPatentPool discussed practical ways to turn that goal into readiness. #DiagnosisForAll

On BDBV, Sheila Mburu reflects on diagnostics availability: ''At Day 100 we still don’t have a true point-of-care test. This is essential for communities that don’t have access to centralised testing.'' @Mburu_Health #100DaysMission #UNGA81

The 100 Days Mission seeks to deliver diagnostics, treatments & vaccines within 100 days of a pandemic threat. At #DevexUNGA81, @IPPSecretariat, @DNDi, @CEPIvaccines, @FINDdx, @UNITAID & @MedsPatentPool will discuss turning that goal into readiness. 👉 dvx.cm/bgxtab

Chagas disease affects ~8 million people worldwide, yet reliable diagnostics remain out of reach for far too many. Through CUIDA Chagas, FIND and its partners are tackling the supply chain, regulatory, and procurement barriers limiting access across Bolivia, Brazil, Colombia, and Paraguay. Check out the latest project newsletter for key insights on Trypanosoma cruzi detection tools and recommendations to expand access across the region. 👇 cuidachagas.org/es/panoramaa… #DiagnosisForAll #ChagasDisease

➡️ FIND’s abstract: “From Months to Days: How Community Leadership Transformed Hepatitis C Care for People who inject drugs (PWIDs)” has been selected for the 12th International Viral Hepatitis Elimination Meeting (IVHEM) 2026 taking place from 3-4 September in Hiroshima, Japan. Read more to learn how operational bottlenecks to hepatitis care can be reduced by embedding lived experience into programme design and empowering communities as equal partners. Abstract available on page 37 of the official abstract book 📖 ve-ame.ams3.digitaloceanspac…

Global commitments are shifting into concrete action to improve access to essential medicines, diagnostics and medical devices for noncommunicable diseases. Availability and affordability of medicines, diagnostics and devices must be supported by: ✅ evidence-based selection and use ✅ stronger regulatory systems ✅ effective demand forecasting and procurement ✅ cohesive pricing policies ✅ inclusion in health benefit packages ✅ financed as part of UHC.

Ending non-communicable diseases requires all hands on deck: governments, donors, the private sector, and global partners. Together, we can #ActOnNCDs. Discover how @HelmsleyTrust is supporting our work: bit.ly/4gIzbNj

📢This Global Week for Action, learn more about FIND's work on NCDs: finddx.org/what-we-do/progra… #DiagnosisForAll #NCDs

⏰It's time to #LeadOnNCDs! 💪FIND has joined the Global Week for Action! Let's call on leaders to: ✅Implement NCD policies ✅Break down siloes in the response ✅Mobilise investments ✅Stay true to the promises ✅Involve people living w/ #NCDs actonncds.org/#ActOnNCDs #DiagnosisForAll